Catapult Your Cell Therapy Research Into the Clinic: CAR NK Cells and Tregs
Explore solutions to advance CAR NK cell and Treg-based therapies from research to clinical applications. Discover products, tools, and services to move your projects forward.
Translating B Cell Epitope Peptide Based Cancer Vaccines to the Clinic - Immunotherapies
Explore novel cancer immunotherapies using B cell epitope peptide vaccines, focusing on PD-L1 and HER-2 inhibitors for improved efficacy and reduced toxicity in clinical applications.
Selective Depletion of CD45RA Expressing Cells to Enrich Antigen-Specific T-Cells for Immunotherapy
Explore techniques for enriching antigen-specific T-cells through selective depletion of CD45RA expressing cells, enhancing immunotherapy potential for virus-associated malignancies.
The Evolving Landscape of Lung Cancer Treatment
Explore advancements in lung cancer treatment, including targeted therapies and immunotherapy. Learn about genetic diagnostics, improved survival rates, and emerging strategies for patient care in this evolving field.
Development of a T Cell Engineering Platform for Fully Individualized Neoantigen-Specific TCR Therapy
Explore a high-throughput platform for identifying neoantigen-reactive TCRs, advancing personalized cancer immunotherapy through T cell engineering and adoptive transfer techniques.
Discovery of a Novel C0702 Restricted Epitope on MAGE A1 and Preclinical Development of an Enhanced TCR-T Cell Therapy
Explore novel C0702 restricted epitope on MAGE A1 and its preclinical development for enhanced anti-tumor T-cell responses in cancer immunotherapy.
Memory-Rich CAR T Cell Engineering by PiggyBac Transposon System for Solid Malignancies
Explore novel CAR-T cell engineering using piggyBac transposon for solid tumors. Learn about memory-rich T cells, manufacturing processes, and potential clinical applications in cancer immunotherapy.
Ecological Dynamics in Cancer-Immune Interaction
Explore ecological dynamics in cancer-immune interactions, focusing on evolution, complex systems, and immunotherapy. Gain insights into genome instability and adaptive immune responses.
Pre-Clinical Investigation of a New PD-L1 B-Cell Epitope Peptide Vaccine PDL1-Vaxx
Explore pre-clinical research on a novel PD-L1 B cell epitope peptide vaccine, PDL1-Vaxx, presented by Jay Overholser from Ohio State University Wexner Medical Center.
Hypoxia Biomarkers - Personalizing Cancer Treatments by Targeting Hypoxia
Explore hypoxia biomarkers for personalized cancer treatments. Learn about tumor microenvironments, prognosis impacts, and treatment resistance. Gain insights into targeting hypoxia for improved patient outcomes.
Understanding Radiation Exposure and Improving Patient Outcomes from Radiotherapy - Part 2
Explore advancements in radiotherapy, including hypofractionation and SBRT, to improve cancer treatment outcomes and patient quality of life.
A Journey from Oncology to Palliative Care
Explore one doctor's inspiring journey from oncology to pioneering palliative care, highlighting the importance of compassionate healthcare for terminally ill patients.
New Approaches to Treatment and Early Diagnosis of Prostate Cancer - Part 2
Explore innovative methods for early prostate cancer diagnosis and treatment with Prof Hashim Ahmed's research insights at Imperial College London.
New Approaches to Treatment and Early Diagnosis of Prostate Cancer - Part 1
Explore cutting-edge research on prostate cancer biology, drug targets, and innovative approaches for early diagnosis and treatment with Professor Johann de Bono.
Exploring the Effects of Heat Therapy-Driven Inosine Generation on Tumor Recurrence
Investigates heat therapy's impact on inosine production and its potential influence on tumor recurrence, offering insights into innovative cancer treatment approaches.
Optimal Control of Combination Immunotherapy for a Virtual Murine Cohort in a Glioblastoma-Immune Dynamics Model
Explore optimal control strategies for combination immunotherapy in glioblastoma treatment using mathematical modeling and virtual murine cohorts.
Stem Cells, Tissue Architecture, and Cancer Evolution - Lecture 1
Explore stem cells, tissue architecture, and cancer evolution in the hematopoietic system through mathematical modeling and applications.
Leveraging Macroscopic Preclinical Data to Simulate Trials on Truly Heterogeneous Populations
Explore macroscopic preclinical data simulation for heterogeneous population trials in cancer treatment research and optimization.
A Modelling-Informed Picture of Residual Disease in Environmentally Mediated Drug Resistance
Explore environmentally mediated drug resistance in cancer through mathematical modeling, focusing on residual disease and its implications for treatment strategies.
Incorporating Drug Toxicity into Models of Adaptive Therapy
Explore adaptive therapy models integrating drug toxicity, enhancing cancer treatment strategies and optimizing patient outcomes.
What Makes Tumors Hot? Insights from Experimental-Computational Integration
Explore experimental-computational integration to understand tumor characteristics and their impact on treatment effectiveness.